This COA was anonymously submitted by a customer via TitrateLab's submission portal. The customer asserts they paid for the test themselves and the chain-of-custody is their own. The report, attributed to Janoshik, indicates a BPC-157 content of 5.32 mg and TB-500 (TB4) content of 5.24 mg for batch 2026/03. This community-tier evidence should be considered alongside other COAs of the same batch, not as confirmation in isolation.